A CRISPR-based COVID-19 test may be a cheaper, at-home alternative to the lab. The test has not yet been approved and it is still only being used for research, but early studies show it is highly accurate. The test also requires minimal equipment and gets results in about an hour. (STAT)

The White House looks to wind down the coronavirus task force. The administration may pass coordination of the U.S. response to federal agencies around the Memorial Day weekend, said Vice President Mike Pence. (Reuters)

U.S. infections are rising outside of the New York area. As local officials ease stay home orders, the infection rates outside of New York are increasing, while New York rates decline. The infection rate over five days, not including New York, increased from 6 per 100,000 people to 7.5 per 100,000. (Associated Press)

Pfizer began U.S. trials of its experimental COVID-19 vaccine. The company has partnered with German pharma company BioNTech to develop the vaccine, which uses messenger RNA. (New York Times)

The coronavirus has mutated and a more contagious strain is now dominant, according to a study. If the virus continues to mutate, it could limit the effectiveness of the coronavirus vaccines being developed by scientists. (CNBC)